XClinical to Present and Exhibit at Upcoming CDISC Interchange in Tokyo

Munich, Germany-May 26, 2008-XClinical (www.xclinical.com), a European vendor of innovative software products for eClinical trials and known for its innovative and user-friendly CDISC ODM certified EDC software suite MARVIN, today announced its comprehensive participation at the CDISC Interchange in Tokyo, Japan.

The exhibition will take place jointly with Asklep (www.asklep.co.jp), the company’s Japanese customer: “Asklep is the first Japanese CRO to join CDISC, and having a CDISC ODM certified partner like XClinical certainly speeds up our goal for having a global standard EDC solution for our clients here in Japan” said Toshio Yoshii, PhD, director of clinical information division at Asklep.
 
XClinical executives will be involved in both CDISC presentations and training sessions. Dr. Claus Lindenau, XClinical’s head of business development, will present a lecture entitled "End To End Processing-A presentation of CDISC certified tools and their benefits in clinical research." The presentation will emphasize how the process from study design via data capture to submission and archival can profit from using a combination of CDISC based software solutions.

Dr. Philippe Verplancke, XClinical’s chief executive officer, will lead the ODM training course on Tuesday, June 3. The training provides an in-depth understanding of the CDISC standards, ODM, and define.xml and how the underlying XML technology can support the complete clinical data management process from CRF design to submission.